MEZIXUS Trademark

Trademark Overview


On Wednesday, November 5, 2025, a trademark application was filed for MEZIXUS with the United States Patent and Trademark Office. The USPTO has given the MEZIXUS trademark a serial number of 99480953. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Saturday, July 4, 2026. This trademark is owned by Celgene Corporation. The MEZIXUS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; Antivirals; Antibodies for medical purposes; Anticoagulants; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes; Biological preparations for the treatment of cancer; Stem cells for medical purposes.
mezixus

General Information


Serial Number99480953
Word MarkMEZIXUS
Filing DateWednesday, November 5, 2025
Status680 - APPROVED FOR PUBLICATION
Status DateSaturday, July 4, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; Antivirals; Antibodies for medical purposes; Anticoagulants; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes; Biological preparations for the treatment of cancer; Stem cells for medical purposes.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 5, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08543
US

Trademark Events


Event DateEvent Description
Wednesday, November 5, 2025NEW APPLICATION ENTERED
Wednesday, November 5, 2025APPLICATION FILING RECEIPT MAILED
Thursday, March 19, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 20, 2026ASSIGNED TO EXAMINER
Saturday, March 28, 2026NON-FINAL ACTION WRITTEN
Saturday, March 28, 2026NON-FINAL ACTION E-MAILED
Saturday, March 28, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 29, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 29, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 29, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, July 4, 2026APPROVED FOR PUB - PRINCIPAL REGISTER